PARIS, Sept 7 (Reuters) - Sanofi-Aventis (SASY.PA: Quote, Profile, Research) has withdrawn its marketing application for its Multaq heart arrhythmia treatment in the European Union, the world’s third-largest drugmaker said on Thursday.
PARIS, Sept 7 (Reuters) - Sanofi-Aventis (SASY.PA: Quote, Profile, Research) has withdrawn its marketing application for its Multaq heart arrhythmia treatment in the European Union, the world’s third-largest drugmaker said on Thursday.
